CD36 and hemorrhagic disease: Interestingly, CD36 deficiencies do not appear to increase the risk of bleeding disorders [145], and deficiencies in CD36 or pharmacological blocking of JNK kinases lead to less thrombotic events in hyperlipidemic mice [143].